NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that it will host a conference call with the financial community to discuss its second quarter 2008 financial results on Thursday, July 24, 2008 at 11:00 a.m. EDT.
